http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0010554-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebb6a553affdc364c91cffe3baf12564
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 1999-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b48e81fdfa8d51d46c074f62e8294db7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97547c61b20027d3fc44901781c1b75f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aee507870e0f6c6b17fe912a41a9236
publicationDate 2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0010554-A3
titleOfInvention Methods and compositions employing optically pure s(+) vigabatrin
abstract Methods and compositions for the prevention, treatment, and/or management of the symptoms of peripheral neuropathy and related disorders, drug or alcohol addiction or the symptoms thereof, or symptoms associated with drug or alcohol withdrawal, using substantially optically pure S(+) vigabatrin, or a pharmaceutically acceptable salt thereof.
priorityDate 1998-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4595697-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0007583-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0509180-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4621145-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5665

Total number of triples: 45.